NYQ · Financial Statements

Bausch Health Companies Inc. (BHC) Revenue, Earnings & Financial Statements

$8.47 NYQ: BHC Market Cap $3.17B

Data as of Nov 17, 2026 close · Statements through the quarter ended Sep 2026 · Source: Financial Modeling Prep (methodology)

Bausch Health Companies Inc. most recently reported annual revenue of $10.3B, net profit of $157.0M. Revenue grew at an average annual rate of 5.0% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Bausch Health Companies Inc.: Revenue rose from $9.7B in 2016 to $10.3B in 2025, a change of +6.1% over 9 years; net profit was positive in 2 of 10 reported years; operating margin moved from -5.8% to 21.3%, a shift of +27.1 percentage points; the most recent year shows net profit of $157.0M.

Income Statement — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Revenue$9.7B$8.7B$8.4B$8.6B$8.0B$8.4B$8.1B$8.8B$9.6B$10.3B
Operating Expenses$10.2B$8.6B$10.8B$8.8B$7.4B$8.0B$7.7B$7.8B$8.1B$8.1B
Operating Profit−$566.0M$102.0M−$2.4B−$203.0M$676.0M$450.0M$454.0M$963.0M$1.5B$2.2B
Operating Margin-5.8%1.2%-28.4%-2.4%8.4%5.3%5.6%11.0%16.1%21.3%
Other Income−$1.9B−$1.8B−$1.8B−$1.6B−$1.6B−$1.5B−$583.0M−$1.4B−$1.4B−$1.8B
Interest$1.8B$1.8B$1.7B$1.6B$1.5B$1.4B$1.5B$1.3B$1.4B$1.6B
Depreciation$2.9B$2.9B$2.8B$2.1B$1.8B$1.6B$1.4B$1.3B$1.3B$1.2B
Profit Before Tax−$2.4B−$1.7B−$4.2B−$1.8B−$934.0M−$1.0B−$129.0M−$390.0M$167.0M$367.0M
Tax rate (%)1.1%238.1%0.2%2.9%40.1%8.5%-64.3%-56.7%143.1%67.3%
Net Profit−$2.4B$2.4B−$4.1B−$1.8B−$559.0M−$948.0M−$225.0M−$592.0M−$46.0M$157.0M
EPS−$6.94$8.59−$11.86−$5.06−$1.57−$2.61−$0.62−$1.62−$0.13$0.43

Quarterly Results — Last 12 Quarters (USD millions)

8 duplicate period labels in the source data were collapsed.

MetricDec '23Mar '24Jun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26Sep '26
Revenue$2.4B$2.2B$2.4B$2.5B$2.6B$2.3B$2.5B$2.7B$2.8B$2.5B$2.9B$2.9B
Operating Expenses$2.0B$1.9B$2.0B$2.2B$2.0B$2.0B$2.1B$2.0B$2.0B$2.0B$2.1B$1.9B
Operating Profit$362.0M$281.0M$389.0M$318.0M$558.0M$292.0M$457.0M$636.0M$829.0M$521.0M$775.0M$983.0M
Operating Margin15.0%13.1%16.2%12.7%21.8%12.9%18.1%23.7%29.6%20.6%27.2%33.8%
Interest$363.0M$355.0M$350.0M$346.0M$337.0M$330.0M$465.0M$412.0M$397.0M$402.0M$396.0M$398.0M
Profit Before Tax−$7.0M−$69.0M$48.0M−$21.0M$209.0M−$47.0M$140.0M$218.0M$56.0M−$1.4B$348.0M$597.0M
Tax rate (%)-571.4%-11.5%102.1%-338.1%53.1%-83.0%8.6%17.0%283.9%-5.7%25.3%-25.3%
Net Profit−$39.0M−$64.0M$10.0M−$85.0M$93.0M−$58.0M$148.0M$179.0M−$112.0M−$1.4B$258.0M$436.0M
EPS−$0.11−$0.17$0.03−$0.23$0.25−$0.16$0.40$0.47−$0.31−$3.79$0.68$0.00

Over the 10 years reported for Bausch Health Companies Inc., borrowings decreased from $29.8B in 2016 to $21.2B in 2025, cash stood at $1.3B in the latest year, shareholders' equity was $10.5B, current assets covered current liabilities 1.47 times.

Balance Sheet — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Total Assets$43.5B$37.5B$27.4B$33.9B$31.2B$29.2B$25.7B$27.4B$26.5B$26.3B
Current Assets$5.1B$4.7B$723.0M$7.0B$5.3B$5.6B$4.2B$5.6B$5.8B$6.1B
Cash$542.0M$720.0M$721.0M$3.2B$605.0M$582.0M$564.0M$947.0M$1.2B$1.3B
Inventory$1.1B$1.0B$934.0M$1.1B$1.1B$993.0M$1.1B$1.5B$1.6B$1.6B
Receivables$2.5B$2.1B$1.9B$1.8B$1.6B$1.8B$1.8B$2.0B$2.1B$2.3B
Fixed Assets$1.3B$1.4B$1.4B$1.5B$1.6B$1.6B$1.6B$1.7B$1.8B$2.1B
Capital Work in Progress$0$0$0$0$0$0$0$0$0$0
Investments$0$0$0$0$0$0$0$0$0$0
Other Assets$15.8B$15.6B$13.1B$13.1B$13.0B$12.5B$11.5B$11.2B$11.1B$11.3B
Total Liabilities$40.3B$31.6B$29.7B$32.7B$30.6B$29.2B$25.4B$27.4B$26.8B$25.9B
Current Liabilities$3.6B$4.3B$3.8B$6.2B$4.9B$5.2B$3.9B$4.3B$6.8B$4.2B
Borrowings$29.8B$25.4B$24.3B$25.9B$23.9B$22.7B$20.8B$22.4B$21.8B$21.2B
Other Liabilities$10.4B$6.1B$5.4B$6.8B$6.7B$6.6B$4.7B$5.0B$5.0B$4.7B
Equity$10.0B$10.1B$10.1B$10.2B$10.2B$10.3B$10.4B$10.4B$10.5B$10.5B
Reserves$3.2B$5.8B$2.7B$1.1B$535.0M−$106.0M−$692.0M−$1.0B−$1.3B−$553.0M

For Bausch Health Companies Inc., operating cash flow was positive in 9 of 10 reported years; free cash flow in the latest year was $1.0B; free cash flow was positive in 9 of 10 years; financing activities used $94.0M in the latest year, which covers debt repayment, dividends and buybacks.

Cash Flow Statement — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Operating Cash Flow$2.1B$2.3B$1.5B$1.5B$1.1B$1.4B−$728.0M$1.0B$1.6B$1.4B
Investing Cash Flow−$416.0M$2.6B−$431.0M−$697.0M−$570.0M$126.0M−$571.0M−$2.4B−$791.0M−$992.0M
Financing Cash Flow−$758.0M−$188.0M−$196.0M−$111.0M−$107.0M−$173.0M−$139.0M−$106.0M−$69.0M−$94.0M
Net Cash Flow−$55.0M$255.0M−$74.0M$2.5B−$1.4B$303.0M−$1.5B$371.0M$239.0M$124.0M
Free Cash Flow$1.8B$2.0B$1.3B$1.2B$802.0M$1.1B−$996.0M$760.0M$1.3B$1.0B

Valuation & Return Ratios

MetricValue
PEG Ratio0.01
EV / EBITDA8.94
FCF Yield58.45%
Quick Ratio1.22
Interest Coverage1.95
Return 1Y26.13%
Return 3Y22.97%
Return 5Y-68.42%

Bausch Health Companies Inc. (BHC) financials — frequently asked questions

What is Bausch Health Companies Inc.'s annual revenue?

Bausch Health Companies Inc. (BHC) reported annual revenue of $10.3B in its most recent fiscal year.

What is Bausch Health Companies Inc.'s net profit?

Bausch Health Companies Inc. (BHC) reported net profit of $157.0M in its most recent fiscal year.

What is BHC EV/EBITDA?

Bausch Health Companies Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is 8.94.

Revenue and earnings of other Drug Manufacturers - Specialty & Generic stocks

TEVA revenue $17.3BZTS revenue $9.5BVTRS revenue $14.3BELAN revenue $4.7BRDY revenue $353.5BALKS revenue $1.5BAMRX revenue $3.0BLNTH revenue $1.5BSUPN revenue $719.0MRGC financialsAll Drug Manufacturers - Specialty & Generic stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens
BHC Overview BHC Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.